MARIANA MARTINASEVIC: Open Payments
NPI 1972587509 · FT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 31 payments from 11 companies in 2025. Trend: 2023 $283 · 2024 $1,001 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $195 |
| Axsome Therapeutics, Inc. | 4 | $191 |
| Tris Pharma Inc | 5 | $111 |
| Corium, LLC | 5 | $70 |
| TMS NeuroHealth Centers Inc. | 1 | $61 |
| Almatica Pharma LLC | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| Bausch Health US, LLC | 1 | $24 |
Products named: CAPLYTA, Auvelity, Dyanavel XR, REXULTI, Azstarys, TMS NeuroHealth Centers Inc., LOREEV XR, HETLIOZ.
Industry payments across FL — which companies pay providers there.
